Our proprietary synergistic technology
How Synology works to deliver ...
How Does Shine Work?
Neubria Shine is a natural mood supplement that acts upon the biological pathways involved in mood maintenance, such as neurochemical pathways and micronutrient deficits. It also helps with common issues related to low mood, such as anxiety and stress.
1. Neurochemical Pathways
Studies demonstrate that vitamins B1, B2, B3, B6, B9, B12 and D, minerals such as zinc, copper, and selenium, as well as choline, impact neurotransmitters such as 5-HT and NE. In addition, curcumin and saffron are potent botanicals that deliver similar effects. Saffron has been demonstrated to be as effective as SSRI antidepressants in clinical studies.
2. Micronutrient Pathways
Studies indicate the importance of consuming vital nutrients daily, as nutrition and mood are intricately linked. However, the daily intake of key dietary elements involved in maintaining mood is generally insufficient in many people. The evidence for B vitamins is the most substantial, with a systematic review supporting the use of a high-dose combination supplement to treat stress and anxiety. Vitamin D, choline, iron, zinc, biotin and magnesium have also been studied, offering some benefits. As no single nutrient stands out as a treatment, a broad-spectrum multivitamin and multimineral approach is preferred.
Substantial evidence in the form of clinical evaluations, systematic reviews and meta-analyses supports the use of ashwagandha, curcumin, saffron, rhodiola and magnesium to treat stress and anxiety.
What Does Shine Contain?
Vitamins: A, D, E, K, C, B1, B2, B3, B5, B6, B12, Folic Acid, Biotin
Minerals: Zinc, Chromium, Selenium, Iron, Manganese, Magnesium, Copper, Iodine, Molybdenum
Supplements: Choline/Citicoline complex
Shine Bright Botanical Blend: Turmeric (Curcumin), Rhodiola Rosea, Ashwagandha, Saffron
St John's Wort can interact with many prescription medicines.
5-HTP is generally converted in the gut to serotonin, where it has a local effect rather than reaching the brain. This increases the risk of gastrointestinal upset.
Whilst studies appear to support the inclusion of SAMe, the doses used in clinical trials, along with observation periods, inclusion criteria, and statistical methods, are not uniform across studies. This makes comparison and assessment of efficacy difficult